Corvus Pharmaceuticals Inc R&D Corporate Call Transcript
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Investor Conference Call. (Operator Instructions)
It is now my pleasure to turn the call over to Zack Kubow of Real Chemistry. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone. Thank you for joining us for the Corvus Pharmaceuticals conference call to provide an overview of the CPI-818 data presented today at the ASH meeting and an update on the company's development programs. This conference call is being webcast with presentation slides. We encourage participants to join the webcast in order to view the slides. You can find the link to join the webcast on the Investor Relations homepage of the Corvus website.
Joining me on the call from the company are Dr. Richard Miller, Chief Executive Officer; Dr. James Rosenbaum, Senior Vice President of Research; and Liev Lea, Chief Financial Officer. The executive team will open the call with some prepared remarks, followed by a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |